Nippon Express (Belgium) N.V./S.A., a Group company of Nippon Express Holdings, Inc., has obtained Good Distribution Practice (GDP) certification effective December 21, 2021 for air and ground forwarding operations, inclusive of inventory control, at a facility in the cargo area of Brussels Airport, evidencing its compliance with GDP standards for the proper distribution of pharmaceuticals.
Belgium has become a hub for pharmaceutical manufacturing and development, hosting numerous global pharmaceutical companies as well as contract manufacturing organizations, vaccine manufacturers and biotechnology research laboratories
NX Belgium has signed a business partnership agreement with Medexi, which specializes in pharmaceutical transport, and obtained GDP certification for operations at a Medexi-owned temperature-controlled 2,000m2 facility dedicated to pharmaceutical products that is capable of both refrigerated (2ºC-8ºC) and constant-temperature (15ºC-25ºC) storage. Medexi’s pharmaceutical knowledge and advanced operational quality will be combined with the NX Group’s international temperature-controlled transport services and warehouse storage functions to provide customers with a pharmaceutical logistics platform
The NX Group will continue stepping up its initiatives in the pharmaceutical industry, identified as a priority industry in the Group’s Business Plan, and globally enhancing and expanding its services to meet the increasingly sophisticated and diversified pharmaceutical transport needs of its customers.
